EA201492097A1 - 5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1 - Google Patents

5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1

Info

Publication number
EA201492097A1
EA201492097A1 EA201492097A EA201492097A EA201492097A1 EA 201492097 A1 EA201492097 A1 EA 201492097A1 EA 201492097 A EA201492097 A EA 201492097A EA 201492097 A EA201492097 A EA 201492097A EA 201492097 A1 EA201492097 A1 EA 201492097A1
Authority
EA
Eurasian Patent Office
Prior art keywords
secretase inhibitors
tiazins
amino
beta secretase
compounds
Prior art date
Application number
EA201492097A
Other languages
English (en)
Other versions
EA026004B1 (ru
Inventor
Ханс Хильперт
Томас Вольтеринг
Original Assignee
Ф. Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф. Хоффманн-Ля Рош Аг filed Critical Ф. Хоффманн-Ля Рош Аг
Publication of EA201492097A1 publication Critical patent/EA201492097A1/ru
Publication of EA026004B1 publication Critical patent/EA026004B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Настоящее изобретение предлагает соединения формулы Iобладающие активностью ингибиторов секретазы ВАСЕ1, их получение, фармацевтические композиции, содержащие такие соединения, их применение в качестве терапевтически активных веществ. Активные соединения по настоящему изобретению полезны в терапевтическом и/или профилактическом лечении, например, болезни Альцгеймера.
EA201492097A 2012-05-24 2013-05-21 5-АМИНО[1,4]ТИАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКРЕТАЗЫ 1 EA026004B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12169353 2012-05-24
PCT/EP2013/060352 WO2013174781A1 (en) 2012-05-24 2013-05-21 5-amino[1,4]thiazines as bace 1 inhibitors

Publications (2)

Publication Number Publication Date
EA201492097A1 true EA201492097A1 (ru) 2015-04-30
EA026004B1 EA026004B1 (ru) 2017-02-28

Family

ID=48534350

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492097A EA026004B1 (ru) 2012-05-24 2013-05-21 5-АМИНО[1,4]ТИАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКРЕТАЗЫ 1

Country Status (22)

Country Link
US (1) US9273042B2 (ru)
EP (1) EP2855469B1 (ru)
JP (1) JP6251249B2 (ru)
KR (1) KR20150014934A (ru)
CN (1) CN104334554B (ru)
AU (1) AU2013265376B2 (ru)
BR (1) BR112014028813A2 (ru)
CA (1) CA2872179A1 (ru)
CL (1) CL2014003123A1 (ru)
CO (1) CO7131369A2 (ru)
CR (1) CR20140495A (ru)
EA (1) EA026004B1 (ru)
HK (1) HK1201261A1 (ru)
IL (1) IL235681A (ru)
MA (1) MA37691B1 (ru)
MX (1) MX2014013839A (ru)
NZ (1) NZ702254A (ru)
PE (1) PE20150021A1 (ru)
PH (1) PH12014502541A1 (ru)
SG (1) SG11201407575PA (ru)
UA (1) UA113438C2 (ru)
WO (1) WO2013174781A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012298983A1 (en) * 2011-08-22 2014-02-27 Merck Sharp & Dohme Corp. 2-spiro-substituted iminothiazines and their mono-and dioxides as BACE inhibitors, compositions and their use
WO2014059185A1 (en) 2012-10-12 2014-04-17 Amgen Inc. Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
US9096615B2 (en) 2013-07-30 2015-08-04 Amgen Inc. Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
US9725468B2 (en) 2013-09-13 2017-08-08 Merck Sharp & Dohme Corp. C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
EP3215514B1 (en) * 2014-11-03 2018-11-21 F. Hoffmann-La Roche AG Bace1 inhibitors
PE20171349A1 (es) 2015-03-20 2017-09-13 Hoffmann La Roche Inhibidores de bace1
JP6895424B2 (ja) * 2015-08-12 2021-06-30 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｂａｃｅ１阻害剤
JP7353708B2 (ja) 2018-04-27 2023-10-02 塩野義製薬株式会社 選択的ｂａｃｅ１阻害活性を有するテトラヒドロピラノオキサジン誘導体
CN110467611B (zh) * 2018-05-11 2022-09-27 广东东阳光药业有限公司 亚氨基噻二嗪二氧化物衍生物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221579A1 (en) * 2004-10-15 2009-09-03 Jeffrey Scott Albert Substituted Amino-Compounds and Uses Thereof
US8461160B2 (en) * 2009-05-08 2013-06-11 Hoffmann-La Roche, Inc. Dihydropyrimidinones
US8188079B2 (en) 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
US20110065695A1 (en) * 2009-09-11 2011-03-17 Jeremy Beauchamp Use of aminodihydrothiazines for the treatment or prevention of diabetes
UA103272C2 (ru) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-амино-5,5-дифтор-5,6-дигидро-4h-оксазины как ингибиторы bace1 и/или bace2
MX2013011947A (es) * 2011-04-13 2014-01-16 Merck Sharp & Dohme Iminotiazinas 5-sustituidas y sus monoxidos y dioxidos como inhibidores de la enzima que encinde la proteina precursora amiloide en el sitio beta, composiciones y su uso.
AU2012298983A1 (en) * 2011-08-22 2014-02-27 Merck Sharp & Dohme Corp. 2-spiro-substituted iminothiazines and their mono-and dioxides as BACE inhibitors, compositions and their use

Also Published As

Publication number Publication date
NZ702254A (en) 2016-08-26
EP2855469B1 (en) 2019-06-19
US20150141413A1 (en) 2015-05-21
UA113438C2 (xx) 2017-01-25
PH12014502541B1 (en) 2015-01-21
IL235681A0 (en) 2015-02-01
CN104334554B (zh) 2017-10-31
EA026004B1 (ru) 2017-02-28
MA37691B1 (fr) 2016-11-30
CA2872179A1 (en) 2013-11-28
AU2013265376B2 (en) 2017-07-20
CL2014003123A1 (es) 2015-02-27
SG11201407575PA (en) 2014-12-30
BR112014028813A2 (pt) 2017-06-27
US9273042B2 (en) 2016-03-01
JP2015517548A (ja) 2015-06-22
EP2855469A1 (en) 2015-04-08
IL235681A (en) 2017-10-31
CN104334554A (zh) 2015-02-04
PH12014502541A1 (en) 2015-01-21
AU2013265376A1 (en) 2014-11-13
KR20150014934A (ko) 2015-02-09
PE20150021A1 (es) 2015-01-28
HK1201261A1 (en) 2015-08-28
JP6251249B2 (ja) 2017-12-20
WO2013174781A1 (en) 2013-11-28
CR20140495A (es) 2014-12-01
CO7131369A2 (es) 2014-12-01
MX2014013839A (es) 2015-02-04
MA37691A1 (fr) 2016-03-31

Similar Documents

Publication Publication Date Title
EA201391786A1 (ru) Галоген-алкил-1,3-оксазины в качестве ингибиторов bace1 и/или bace2
EA201391670A1 (ru) 1,3-оксазины в качестве ингибиторов bace1 и/или bace2
EA201391752A1 (ru) Спиро-[1,3]-оксазины и спиро-[1,4]-оксазепины в качестве ингибиторов bace1 и/или bace2
MX2015008957A (es) Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1).
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
UA113538C2 (xx) Фторметил-5,6-дигідро-4h-$1,3]оксазини
EA201492097A1 (ru) 5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1
MX2013007558A (es) 1,4-oxazinas como inhibidores de los genes enzima de segmentacion de la proteina precursora del sitio 1 y/o 2 (bace1 y/o bace2).
MX2013010795A (es) 1,3 oxazinas como inhibidores de beta-secretasa 1 (bace 1) y/o la beta-secretasa 2 (beta 2).
MX2013007957A (es) 1,4-oxazinas como inhibidores de los genes de enzima de segmentacion de la proteina precursora amiloide del sitio beta 1 y/o (bace1 y/o bace2).
EA201200176A1 (ru) Производные оксазина и их применение для лечения неврологических нарушений
MX2013014007A (es) [1,3] oxazinas.
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA201590066A1 (ru) Дифторгексагидроциклопентаоксазинилы и дифторгексагидробензоксазинилы в качестве ингибиторов бета-секретазы 1
MX2013008478A (es) 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2).
MX2014003408A (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1).
MX2013014194A (es) 1,3-tiazepinas fusionadas a ciclopropilo como inhibidores de beta-secretasa 1 (bace) y/o beta-secretasa 2 (bace 2).
PH12017501668A1 (en) Bace1 inhibitors
MX2016006906A (es) 5-aril-1-imino-1-oxo-[1,2,4]tiadiazinas.
MX2016016061A (es) 2,2,2-trifluoroetil-tiadiazinas.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU